In Brief
- A new pharmaceutical category is being introduced to expand the range of non-prescription drugs.
- Access to these medicines is conditional upon receiving mandatory counseling from a pharmacist.
- The legislative changes are scheduled to take effect on January 1, 2027.
Patients will soon gain access to a wider range of medications without needing a doctor’s prescription, provided they consult with a pharmacist at the point of sale. This legislative shift introduces a specialized ‘pharmacist-assisted’ category, ensuring that while availability increases, patient safety remains prioritized through professional guidance.
A new category for safer self-care
The core of the proposal is the creation of a new segment within the pharmaceutical market. By allowing certain drugs to be sold without a prescription under the condition of mandatory counseling, the government aims to streamline access to effective treatments. This model ensures that patients receive necessary medical information and usage instructions directly from a qualified professional, bridging the gap between prescription-only drugs and standard over-the-counter products.
Why the change is happening
The primary objective is to increase the availability of medicines while maintaining high safety standards. By shifting specific drugs into this new category, the system reduces the administrative burden on primary care providers while ensuring that the patient is not left to navigate their treatment alone. The requirement for pharmacist intervention acts as a safeguard, ensuring that the medication is appropriate for the individual’s specific health needs.
Who is affected?
Individuals and Businesses
- Patients: Will experience improved access to a broader selection of medications, allowing for faster treatment of minor ailments without a prior doctor’s visit.
- Pharmacies: Must implement new routines to ensure that the mandatory counseling process is documented and performed correctly for all sales within the new pharmaceutical category.